Novartis launches Extavia, a new therapeutic option to help patients combat devastating symptoms of multiple sclerosis

Links shared publicly online about this topic.

2,313
total visits

Novartis launches Extavia, a new therapeutic option to help patients combat devastating symptoms of multiple sclerosis

Basel, January 22, 2009 - Novartis has today announced the launch of Extavia, a new version of the standard-of-care for relapsing forms of multiple sclerosis (MS), providing patients and physicians with an alternative option to help manage this devastating disease.

View full resource at novartis.com

Tags: Multiple Sclerosis, Disease and Condition, Novartis, Physician